Header Logo

Connection

Ann Moormann to Epstein-Barr Virus Infections

Back to Details
This is a "connection" page, showing publications Ann Moormann has written about Epstein-Barr Virus Infections.
Ann Moormann
Connection Strength
6.726
Epstein-Barr Virus Infections
  1. Oluoch PO, Forconi CS, Oduor CI, Ritacco DA, Akala HM, Bailey JA, Juliano JJ, Ong'echa JM, M?nz C, Moormann AM. Distinctive Kaposi Sarcoma-Associated Herpesvirus Serological Profile during Acute Plasmodium falciparum Malaria Episodes. Int J Mol Sci. 2023 Apr 04; 24(7).
    View in: PubMed
    Score: 0.772
  2. Saikumar Lakshmi P, Oduor CI, Forconi CS, M'Bana V, Bly C, Gerstein RM, Otieno JA, Ong'echa JM, M?nz C, Luftig MA, Brehm MA, Bailey JA, Moormann AM. Endemic Burkitt lymphoma avatar mouse models for exploring inter-patient tumor variation and testing targeted therapies. Life Sci Alliance. 2023 05; 6(5).
    View in: PubMed
    Score: 0.768
  3. Kaymaz Y, Oduor CI, Aydemir O, Luftig MA, Otieno JA, Ong'echa JM, Bailey JA, Moormann AM. Epstein-Barr Virus Genomes Reveal Population Structure and Type 1 Association with Endemic Burkitt Lymphoma. J Virol. 2020 08 17; 94(17).
    View in: PubMed
    Score: 0.643
  4. Moormann AM, Bailey JA. Malaria - how this parasitic infection aids and abets EBV-associated Burkitt lymphomagenesis. Curr Opin Virol. 2016 10; 20:78-84.
    View in: PubMed
    Score: 0.491
  5. Matar CG, Jacobs NT, Speck SH, Lamb TJ, Moormann AM. Does EBV alter the pathogenesis of malaria? Parasite Immunol. 2015 Sep; 37(9):433-45.
    View in: PubMed
    Score: 0.456
  6. Rochford R, Moormann AM. Burkitt's Lymphoma. Curr Top Microbiol Immunol. 2015; 390(Pt 1):267-85.
    View in: PubMed
    Score: 0.436
  7. Moormann AM, Snider CJ, Chelimo K. The company malaria keeps: how co-infection with Epstein-Barr virus leads to endemic Burkitt lymphoma. Curr Opin Infect Dis. 2011 Oct; 24(5):435-41.
    View in: PubMed
    Score: 0.348
  8. M?nz C, Moormann A. Immune escape by Epstein-Barr virus associated malignancies. Semin Cancer Biol. 2008 Dec; 18(6):381-7.
    View in: PubMed
    Score: 0.283
  9. Kim IE, Fola AA, Puig E, Maina TK, Hui ST, Ma H, Zuckerman K, Agwati EO, Leonetti A, Crudale R, Luftig MA, Moormann AM, Oduor C, Bailey JA. Comparison of nanopore with illumina whole genome assemblies of the Epstein-Barr virus in Burkitt lymphoma. Sci Rep. 2025 Mar 31; 15(1):10970.
    View in: PubMed
    Score: 0.222
  10. Moormann AM, Chelimo K, Sumba OP, Lutzke ML, Ploutz-Snyder R, Newton D, Kazura J, Rochford R. Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children. J Infect Dis. 2005 Apr 15; 191(8):1233-8.
    View in: PubMed
    Score: 0.221
  11. Kim IE, Oduor C, Stamp J, Luftig MA, Moormann AM, Crawford L, Bailey JA. Incorporation of Epstein-Barr viral variation implicates significance of Latent Membrane Protein 1 in survival prediction and prognostic subgrouping in Burkitt lymphoma. Int J Cancer. 2025 Jun 01; 156(11):2188-2199.
    View in: PubMed
    Score: 0.221
  12. Rochford R, Cannon MJ, Moormann AM. Endemic Burkitt's lymphoma: a polymicrobial disease? Nat Rev Microbiol. 2005 02; 3(2):182-7.
    View in: PubMed
    Score: 0.219
  13. Willard KA, Barry AP, Oduor CI, Ong'echa JM, Bailey JA, Moormann AM, Luftig MA. Viral and host factors drive a type 1 Epstein-Barr virus spontaneous lytic phenotype. mBio. 2023 Dec 19; 14(6):e0220423.
    View in: PubMed
    Score: 0.201
  14. Muriuki BM, Forconi CS, Kirwa EK, Maina TK, Ariera BO, Bailey JA, Ghansah A, Moormann AM, Ong'echa JM. Evaluation of KIR3DL1/KIR3DS1 allelic polymorphisms in Kenyan children with endemic Burkitt lymphoma. PLoS One. 2023; 18(8):e0275046.
    View in: PubMed
    Score: 0.199
  15. Agwati EO, Oduor CI, Ayieko C, Ong'echa JM, Moormann AM, Bailey JA. Profiling genome-wide recombination in Epstein Barr virus reveals type-specific patterns and associations with endemic-Burkitt lymphoma. Virol J. 2022 12 08; 19(1):208.
    View in: PubMed
    Score: 0.189
  16. Caduff N, McHugh D, Rieble L, Forconi CS, Ong'echa JM, Oluoch PO, Raykova A, Murer A, B?ni M, Zuppiger L, Schulz TF, Blackbourn DJ, Chijioke O, Moormann AM, M?nz C. KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in?vivo upon KSHV/EBV dual infection. Cell Rep. 2021 05 04; 35(5):109056.
    View in: PubMed
    Score: 0.169
  17. Movassagh M, Oduor C, Forconi C, Moormann AM, Bailey JA. Sensitive detection of EBV microRNAs across cancer spectrum reveals association with decreased survival in adult acute myelocytic leukemia. Sci Rep. 2019 12 30; 9(1):20321.
    View in: PubMed
    Score: 0.154
  18. Kaymaz Y, Oduor CI, Yu H, Otieno JA, Ong'echa JM, Moormann AM, Bailey JA. Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type-Specific Differences. Mol Cancer Res. 2017 05; 15(5):563-576.
    View in: PubMed
    Score: 0.128
  19. Reynaldi A, Schlub TE, Piriou E, Ogolla S, Sumba OP, Moormann AM, Rochford R, Davenport MP. Modeling of EBV Infection and Antibody Responses in Kenyan Infants With Different Levels of Malaria Exposure Shows Maternal Antibody Decay is a Major Determinant of Early EBV Infection. J Infect Dis. 2016 Nov 01; 214(9):1390-1398.
    View in: PubMed
    Score: 0.122
  20. Reynaldi A, Schlub TE, Chelimo K, Sumba PO, Piriou E, Ogolla S, Moormann AM, Rochford R, Davenport MP. Impact of Plasmodium falciparum Coinfection on Longitudinal Epstein-Barr Virus Kinetics in Kenyan Children. J Infect Dis. 2016 Mar 15; 213(6):985-91.
    View in: PubMed
    Score: 0.115
  21. Chattopadhyay PK, Chelimo K, Embury PB, Mulama DH, Sumba PO, Gostick E, Ladell K, Brodie TM, Vulule J, Roederer M, Moormann AM, Price DA. Holoendemic malaria exposure is associated with altered Epstein-Barr virus-specific CD8(+) T-cell differentiation. J Virol. 2013 Feb; 87(3):1779-88.
    View in: PubMed
    Score: 0.094
  22. Piriou E, Asito AS, Sumba PO, Fiore N, Middeldorp JM, Moormann AM, Ploutz-Snyder R, Rochford R. Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma. J Infect Dis. 2012 Mar 15; 205(6):906-13.
    View in: PubMed
    Score: 0.089
  23. Piriou E, Kimmel R, Chelimo K, Middeldorp JM, Odada PS, Ploutz-Snyder R, Moormann AM, Rochford R. Serological evidence for long-term Epstein-Barr virus reactivation in children living in a holoendemic malaria region of Kenya. J Med Virol. 2009 Jun; 81(6):1088-93.
    View in: PubMed
    Score: 0.074
  24. Moormann AM, Heller KN, Chelimo K, Embury P, Ploutz-Snyder R, Otieno JA, Oduor M, M?nz C, Rochford R. Children with endemic Burkitt lymphoma are deficient in EBNA1-specific IFN-gamma T cell responses. Int J Cancer. 2009 Apr 01; 124(7):1721-6.
    View in: PubMed
    Score: 0.073
  25. Quintana MDP, Smith-Togobo C, Moormann A, Hviid L. Endemic Burkitt lymphoma - an aggressive childhood cancer linked to Plasmodium falciparum exposure, but not to exposure to other malaria parasites. APMIS. 2020 Feb; 128(2):129-135.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.